Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Integrated organ immunity: a path to a universal vaccine

Nature Reviews Immunology volume 24, pages 81–82 (2024)Cite this article

Subjects

Here, I introduce the concept of ‘integrated organ immunity’ to explain how the innate and adaptive immune systems and non-haematopoietic cells can interact in tissues to generate enduring protective immunity against diverse pathogens in an antigen-agnostic manner. Considering immune responses through this framework could enable the design of a new class of vaccines termed ‘universal vaccines’ that are not pathogen specific.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Harnessing integrated organ immunity for universal vaccines.

References

  1. Netea, M. G. et al. Defining trained immunity and its role in health and disease. Nat. Rev. Immunol. 20, 375–388 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Ziogas, A. et al. Trained immunity: target for prophylaxis and therapy. Cell Host Microbe 31, 1776–1791 (2023).

    Article  CAS  PubMed  Google Scholar 

  3. Aaby, P. et al. Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? J. Infect. Dis. 204, 245–252 (2011).

    Article  CAS  PubMed  Google Scholar 

  4. Higgins, J. P. et al. Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review. BMJ 355, i5170 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Arts, R. J. W. et al. BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host Microbe 23, 89–100 e105 (2018).

    Article  CAS  PubMed  Google Scholar 

  6. Wimmers, F. et al. The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination. Cell 184, 3915–3935 e3921 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Lee, A. et al. BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistance. Nat. Immunol. 25, 41–53 (2024).

    Article  CAS  PubMed  Google Scholar 

  8. Kaufmann, E. et al. BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis. Cell 172, 176–190 e119 (2018).

    Article  CAS  PubMed  Google Scholar 

  9. Darrah, P. A. et al. Prevention of tuberculosis in macaques after intravenous BCG immunization. Nature 577, 95–102 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Hilligan, K. L. et al. Pre-existing interferon gamma conditions the lung to mediate early control of SARS-CoV-2. Preprint at bioRxiv https://doi.org/10.1101/2023.07.15.549135 (2023).

  11. Arunachalam, P. S. et al. Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature 596, 410–416 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Li, C. et al. Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine. Nat. Immunol. 23, 543–555 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Pittet, L. F. et al. Randomized trial of BCG vaccine to protect against Covid-19 in health care workers. N. Engl. J. Med. 388, 1582–1596 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Bruxvoort, K. J. et al. Recombinant adjuvanted zoster vaccine and reduced risk of coronavirus disease 2019 diagnosis and hospitalization in older adults. J. Inf. Dis. 225, 1915–1922 (2022).

    Article  CAS  Google Scholar 

  15. Usher, A. D. CEPI launches 100-day vaccine ‘moonshot’. Lancet 399, 1107–1108 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

I thank the National Institutes of Health, the Bill and Melinda Gates Foundation, Open Philanthropy, and other anonymous donors for their generous support of the work in my laboratory at Stanford.

Author information

Authors and Affiliations

  1. Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA

    Bali Pulendran

  2. Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA

    Bali Pulendran

  3. Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford University, Stanford, CA, USA

    Bali Pulendran

Authors
  1. Bali Pulendran
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bali Pulendran.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pulendran, B. Integrated organ immunity: a path to a universal vaccine. Nat Rev Immunol 24, 81–82 (2024). https://doi.org/10.1038/s41577-024-00990-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41577-024-00990-1

Search

Advanced search

Quick links

Nature Briefing Microbiology

Sign up for the Nature Briefing: Microbiology newsletter — what matters in microbiology research, free to your inbox weekly.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing: Microbiology